BRUGNOLI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 4.245
AS - Asia 2.184
EU - Europa 1.617
SA - Sud America 439
AF - Africa 42
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.529
Nazione #
US - Stati Uniti d'America 4.162
SG - Singapore 896
CN - Cina 621
IT - Italia 538
BR - Brasile 376
PL - Polonia 265
DE - Germania 215
HK - Hong Kong 199
VN - Vietnam 172
UA - Ucraina 151
GB - Regno Unito 136
TR - Turchia 98
FI - Finlandia 78
ID - Indonesia 68
RU - Federazione Russa 56
CA - Canada 46
SE - Svezia 42
MX - Messico 32
IN - India 30
FR - Francia 29
NL - Olanda 28
AR - Argentina 27
ZA - Sudafrica 25
BD - Bangladesh 21
ES - Italia 19
JP - Giappone 19
AT - Austria 16
LT - Lituania 15
BE - Belgio 14
EC - Ecuador 12
CO - Colombia 9
IQ - Iraq 9
MA - Marocco 9
KR - Corea 7
PK - Pakistan 7
IR - Iran 6
PY - Paraguay 6
SA - Arabia Saudita 5
UZ - Uzbekistan 5
CL - Cile 4
CZ - Repubblica Ceca 4
TW - Taiwan 4
AZ - Azerbaigian 3
KE - Kenya 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
GY - Guiana 2
PH - Filippine 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
MK - Macedonia 1
MU - Mauritius 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.529
Città #
Singapore 482
Ashburn 464
Fairfield 391
Woodbridge 359
Ferrara 299
Warsaw 263
Beijing 243
Santa Clara 227
Houston 212
Ann Arbor 206
Chandler 206
Hong Kong 199
Seattle 162
Jacksonville 152
Dallas 150
Cambridge 148
Wilmington 131
Los Angeles 100
New York 95
Izmir 66
Munich 65
Princeton 57
Jakarta 55
Ho Chi Minh City 54
Nanjing 52
Shanghai 39
Buffalo 37
São Paulo 35
San Diego 33
Hanoi 32
The Dalles 28
Addison 25
Turku 25
Boardman 24
Bologna 21
Chicago 21
Manchester 21
Johannesburg 20
London 20
Helsinki 19
Nanchang 19
Brooklyn 17
Hefei 17
Milan 16
Nuremberg 16
Toronto 16
Atlanta 15
Bremen 15
Montreal 15
Orem 15
Auburn Hills 14
Shenyang 14
Stockholm 14
Brussels 13
Chennai 13
Denver 13
Tianjin 13
Tokyo 13
Dearborn 12
Dong Ket 12
Falkenstein 12
Mexico City 12
Poplar 12
Rimini 12
Falls Church 11
San Francisco 11
Moscow 10
Rio de Janeiro 10
Boston 9
Changsha 9
Phoenix 9
Vienna 9
Belo Horizonte 8
Jinan 8
Mountain View 8
Norwalk 8
Campinas 7
Catania 7
Dhaka 7
Frankfurt am Main 7
Goiânia 7
Haiphong 7
Ankara 6
Ariano nel Polesine 6
Augusta 6
Biên Hòa 6
Council Bluffs 6
Düsseldorf 6
Guangzhou 6
Leawood 6
Salt Lake City 6
Asunción 5
Brasília 5
Buenos Aires 5
Caxias do Sul 5
Curitiba 5
Da Nang 5
Guayaquil 5
Hebei 5
Hải Dương 5
Totale 5.829
Nome #
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report 244
Phospholipase C-beta2 promotes mitosis and migration of human breast cancer-derived cells 217
Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit 209
Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells 202
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 195
CD133 in Breast Cancer Cells: More than a Stem Cell Marker 194
In triple negative breast tumor cells, PLC-beta 2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness 192
Up-modulation of PLC-beta2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: A promising target for preventing progression of TNBC 184
Mitigation of tumor necrosis factor alpha cytotoxicity by aurintricarboxylic acid in human peripheral B lymphocytes 181
VAV PROMOTES DIFFERENTIATION OF HUMAN TUMORAL MYELOID PRECURSORS 180
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process 176
Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells 175
Mass spectrometry-based identification of Y745 of Vav1 as a tyrosine residue crucial in maturation of acute promyelocytic leukemia-derived cells 172
Vav1 downmodulates Akt in different breast cancer subtypes: A new promising chance to improve breast cancer outcome 168
Association of PI 3-K with tyrosine phosphorylated Vav is essential for its activity in neutrophil-like maturation of myeloid cells 165
Retinoic acid maintains differentiated cell morphology and functions in long-term cultured porcine hepatocytes: Obtaining functional cells for prolonged treatments with bioartificial liver 159
Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid 157
Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: Role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation 156
PLC-β2 is highly expressed in breast cancer and is associated with a poor outcome: A study on tissue microarrays 155
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 153
Vav1 modulates protein expression during ATRA-lnduced maturation of APL-derived promyelocytes: A proteomic-based analysis 153
hnRNP K in PU.1-containing complexes recruited at theCD11bpromoter: a distinct role in modulating granulocytic and monocytic differentiation of AML-derived cells 152
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 151
Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia-derived cells 151
Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes 144
Ethanol-based garlic extract prevents malignant evolution of non-invasive breast tumor cells induced by moderate hypoxia 141
The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells 139
Vav1 in differentiation of tumoral promyelocytes 138
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 137
null 134
PLCB2 (phospholipase C, beta 2). 133
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 132
Vav1: a key player in aginist-induced differentiation of promyelocytes from Acute Myeloid leukemia (APL). 124
RNA interference in the study of molecular mechanisms activated during agonist induced differentiation of acute promyelocytic leukemia derived promyelocytes 122
PLC-beta2 monitors the drug-induced release of differentiation blockade in tumoral myeloid precursors 120
Nuclear inositide-metabolism in granulocytic differentiation of myeloid cells. 120
Pulsed Electromagnetic Fields Modulate miRNAs During Osteogenic Differentiation of Bone Mesenchymal Stem Cells: a Possible Role in the Osteogenic-angiogenic Coupling 120
Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells 118
Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells 116
Effects of garlic extract on breast tumor cells: a phenotype dependent modulation of morphology, cell cycle and invasive potential 110
Imidazo[1,2-b]pyrazole-7-carboxamide derivative induces differentiation-coupled apoptosis of immature myeloid cells such as acute myeloid leukemia and myeloid-derived suppressor cells 107
Chlorogenic acid permeation across intestinal cell monolayers: influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 105
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 99
The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO 99
Inositide-modifying enzymes: a cooperative role in regulating nuclear morphology during differentiation of myeloid cells. 99
EVALUATION OF DIFFERENT STORAGE CONDITIONS ON CHEMICAL COMPOSITION AND BIOACTIVE COMPOUNDS OF VOGHIERA GARLIC PDO 92
The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma 91
Phosphoinositide 3-kinase is associated to the nucleus of HL-60 cells and is involved in their ATRA-induced granulocytic differentiation 89
In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness 89
Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines 86
Effects of Garlic on Breast Tumor Cells with a Triple Negative Phenotype: Peculiar Subtype-Dependent Down-Modulation of Akt Signaling 86
Insights into the development of insulin-producing cells: Precursors correlated involvement of microRNA panels 85
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 84
Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity 83
Selective up-regulation of phospholipase C-beta 2 during granulocytic differentiation of normal and leukemic hematopoietic progenitors 81
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 74
Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype 67
ROLE OF VAV1 IN DIFFERENTIATION ALONG THE MONOCYTIC-MACROPHAGIC LINEAGE OF TUMORAL MYELOID PRECURSORS 67
Vav1 regulates phenotypic differentiation of AML-derived promyelocytes to monocytes/macrophages 66
Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA) 65
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2 65
Modulation of Vav1 in differentiation of hiPSCs to β cells: a potential strategy to enhance outcomes of in vitro-generated insulin producing cells transplantation 58
PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential 58
THE MULTIDOMAIN PROTEIN VAV1 IN THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO INSULIN-PRODUCING CELLS 57
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches 57
Novel Insights into the Mechanism of Action and Modulation of Microvesicle Release by Nitroxoline in Pancreatic Cancer Cells Using Integrative Proteomic and Functional Analyses 57
Metabolic fingerprinting of breast cancer cell lines: discovering similarities and differences 56
PLC-beta2 activity on actin-associated polyphosphoinositides promotes migration of differentiating tumoral myeloid precursors. 56
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 50
Effects of garlic on Breast Tumor cells: a selective modulation of growth, invasive potential and Akt signaling 50
null 45
Phenotype-dependent role of Vav1 in down-modulating Akt in invasive breast tumor cells 35
Dual Role of Diallyl Disulfide (DADS) on Invasive Potential and β-Catenin Dynamics in HER2-Positive Breast Cancer Cells 16
Inhibition of cancerous properties of triple-negative MDA-MB-436 cells by targeting the K+ voltage-dependent Kv2.1 channel 15
MicroRNA 375 and diabetes: A key regulator of β cell function and a promising non-invasive biomarker 11
Totale 8.689
Categoria #
all - tutte 43.757
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.061
Totale 44.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021502 0 0 0 0 0 88 71 94 26 107 65 51
2021/2022523 16 46 49 29 15 44 29 34 12 54 46 149
2022/2023536 52 33 29 59 74 54 26 73 62 2 42 30
2023/2024384 31 37 5 13 21 79 17 48 11 9 17 96
2024/20251.702 46 50 146 77 201 157 73 109 201 218 253 171
2025/20262.662 517 253 475 610 743 64 0 0 0 0 0 0
Totale 8.689